ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1253

Patient Reported Outcome Measures: Assessing Resident Physician Acceptance of the Routine Assessment of Patient Index Data 3 Survey and its Impact on Physician-Patient Relationship

Nisha Sapkota1, Chana Birnbaum2, Henna Levitansky2, Yevheniia Andriushchenko2, Saadia Malik2, Melissa Andrade2, Sarang Choi2 and Sima Terebelo2, 1Interfaith Medical Center, One Broolyn Health, Brooklyn, NY, 2Brookdale Hospital Medical Center, One Brooklyn Health, Brooklyn

Meeting: ACR Convergence 2025

Keywords: Measurement, pain, Patient reported outcomes, quality of life, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1248–1271) Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: When treating patients with rheumatological conditions, building a strong physician-patient relationship plays an important role in determining disease outcomes. The Routine Assessment of Patient Index Data 3 (RAPID3) is a patient reported outcome measure which is administered to patients in rheumatology clinics. We initiated use of the RAPID3 assessment in our clinic with the hypothesis that in addition to assessing patient reported outcomes, this tool would help residents better understand the disabling effects of rheumatological diseases and that it would also enhance physician-patient relationships by giving the patient a voice to express themselves and explain the impact of their diseases on their daily lives. This study analyzes the impact of RAPID3 on resident education, doctor-patient relationships, and patient care using a 360-degree assessment of both the resident physician and patient perspectives.

Methods: RAPID3 surveys were administered to all patients (regardless of diagnosis) during their clinic visit, with assistance as needed by the resident physician, and responses were discussed with the patient during the clinic visit, in two resident-staffed outpatient Rheumatology teaching clinics at our institution over a 6-month period. After the clinic visit, patient surveys were administered to patients by research volunteers (CB, HL) who were not part of the medical team. Anonymous surveys were also sent to all resident physicians after each clinic session. The surveys included both yes/no questions as well as 5-point Likert scale questions. The mean plus standard deviation was then calculated for each answer.

Results: Resident Belief of Impact of RAPID3 on physician-patient relationships: 89.2% residents agreed/strongly agreed that RAPID3 helped them understand their patient better. 89.2% agreed that RAPID3 helped them get a deeper understanding of the degree of disability patients experience. 86.5% of residents felt that patients were more comfortable with them after completing the survey (Table1).Resident Acceptance of RAPID3: 91.9% disagreed/strongly disagreed that RAPID3 is a waste of clinic time. 97.3% agreed that the RAPID3 should be a regular part of all future clinics (Table 1).Patient Acceptance of RAPID3: 86.5% of patients agreed/strongly agreed that the RAPID3 should be used at every visit (Table 2).Patient Belief of Impact of RAPID3 on physician-patient relationships: 89.9% of patients felt more comfortable with their physician after the survey. 93.3% of patients felt the survey helped the physician better understand the daily impact of disease (Table 2).

Conclusion: RAPID3 was well accepted among patients and residents. It serves as a helpful tool for residents (normally young and healthy) to realize the barriers that patients with rheumatologic and musculoskeletal diseases face. It helped improve patient-physician communication and helped patients feel more comfortable with their physician. Future research may include how to shorten the RAPID3 (i.e., which questions are superfluous) and try to administer RAPID3 regularly prior to visits to always prioritize patient reported outcomes.

Supporting image 1

Supporting image 2


Disclosures: N. Sapkota: None; C. Birnbaum: None; H. Levitansky: None; Y. Andriushchenko: None; S. Malik: None; M. Andrade: None; S. Choi: None; S. Terebelo: None.

To cite this abstract in AMA style:

Sapkota N, Birnbaum C, Levitansky H, Andriushchenko Y, Malik S, Andrade M, Choi S, Terebelo S. Patient Reported Outcome Measures: Assessing Resident Physician Acceptance of the Routine Assessment of Patient Index Data 3 Survey and its Impact on Physician-Patient Relationship [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/patient-reported-outcome-measures-assessing-resident-physician-acceptance-of-the-routine-assessment-of-patient-index-data-3-survey-and-its-impact-on-physician-patient-relationship/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcome-measures-assessing-resident-physician-acceptance-of-the-routine-assessment-of-patient-index-data-3-survey-and-its-impact-on-physician-patient-relationship/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology